Zoetis Inc. (NYSE:ZTS) Shares Acquired by Lantz Financial LLC

Lantz Financial LLC lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 18.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,236 shares of the company’s stock after purchasing an additional 194 shares during the period. Lantz Financial LLC’s holdings in Zoetis were worth $201,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in ZTS. Darwin Wealth Management LLC acquired a new position in Zoetis in the third quarter valued at approximately $31,000. First Personal Financial Services acquired a new position in Zoetis in the third quarter valued at approximately $33,000. Capital Performance Advisors LLP acquired a new position in Zoetis in the third quarter valued at approximately $33,000. Dunhill Financial LLC lifted its holdings in Zoetis by 80.6% in the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after acquiring an additional 75 shares during the last quarter. Finally, Quarry LP lifted its holdings in Zoetis by 273.2% in the second quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after acquiring an additional 153 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently commented on ZTS shares. JPMorgan Chase & Co. upped their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. UBS Group assumed coverage on Zoetis in a research report on Monday, December 9th. They issued a “neutral” rating and a $196.00 target price on the stock. Leerink Partners assumed coverage on Zoetis in a research report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price on the stock. Finally, Stifel Nicolaus cut their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Zoetis presently has an average rating of “Buy” and a consensus target price of $211.89.

Zoetis Stock Up 1.0 %

Zoetis stock opened at $168.63 on Friday. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.53. The stock’s fifty day simple moving average is $170.10 and its 200-day simple moving average is $179.66. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The firm has a market capitalization of $76.08 billion, a P/E ratio of 31.70, a P/E/G ratio of 2.57 and a beta of 0.89.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The business had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. During the same quarter in the prior year, the company earned $1.36 earnings per share. The company’s revenue was up 11.6% on a year-over-year basis. As a group, equities analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.19%. The ex-dividend date is Tuesday, January 21st. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. Zoetis’s dividend payout ratio is 37.59%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.